APA (7th ed.) Citation

M, A., HM, A., AM, A., & G, E. B. (2026). Targeting the GSK-3β/mTOR axis to overcome chemoresistance in gestational choriocarcinoma: Molecular mechanisms and therapeutic opportunities. Cancer chemotherapy and pharmacology, 96(1), . https://doi.org/10.1007/s00280-026-04896-8

Chicago Style (17th ed.) Citation

M, Al-Hajeili, Al-Kuraishy HM, Abdelaziz AM, and El-Saber Batiha G. "Targeting the GSK-3β/mTOR Axis to Overcome Chemoresistance in Gestational Choriocarcinoma: Molecular Mechanisms and Therapeutic Opportunities." Cancer Chemotherapy and Pharmacology 96, no. 1 (2026). https://doi.org/10.1007/s00280-026-04896-8.

MLA (9th ed.) Citation

M, Al-Hajeili, et al. "Targeting the GSK-3β/mTOR Axis to Overcome Chemoresistance in Gestational Choriocarcinoma: Molecular Mechanisms and Therapeutic Opportunities." Cancer Chemotherapy and Pharmacology, vol. 96, no. 1, 2026, https://doi.org/10.1007/s00280-026-04896-8.